Waters Corporation
WAT Healthcare Diagnostics & Research
Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024. In the quarter to June 2026, revenue grew 113.4%, EPS fell 156.3%, free cash flow grew 750.0% and total debt rose 308.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
Follow WAT
Waters Corporation (WAT) Return on assets
Waters Corporation's return on assets over the twelve months to 30 June 2026 was 1.13%, down 12.2 percentage points from fiscal 2025 (13.4%). Over the past ten years it has ranged from 0.41% (fiscal 2017) to 23.4% (fiscal 2021); the current reading is higher than 45% of that period. That is above the Diagnostics & Research industry median of −6.71% and above the Healthcare sector median of −30.9%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 13.4% | (0.55) |
| FY2024 | 13.9% | (2.34) |
| FY2023 | 16.2% | (5.96) |
| FY2022 | 22.2% | (1.15) |
| FY2021 | 23.4% | 4.02 |
| FY2020 | 19.3% | 0.48 |
| FY2019 | 18.9% | 5.73 |
| FY2018 | 13.1% | 12.71 |
| FY2017 | 0.41% | (11.27) |
| FY2016 | 11.7% | 0.16 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| IDXX IDEXX Laboratories, Inc. compare | 33.7% |
| MTD Mettler-Toledo International, Inc. compare | 25.6% |
| ILMN Illumina, Inc. compare | 13.0% |
| A Agilent Technologies, Inc. compare | 11.0% |
| DGX Quest Diagnostics Incorporated compare | 6.43% |
| LH Labcorp Holdings Inc. compare | 5.48% |
| IQV IQVIA Holdings Inc. compare | 4.70% |
| WAT Waters Corporation | 1.13% |
| NTRA Natera, Inc. compare | −8.71% |
| Diagnostics & Research industry median | −6.71% |
| Healthcare sector median | −30.9% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on WAT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement